ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Computational Medicine and Drug Designing Software Market Research Report 2025
Published Date: June 2025
|
Report Code: QYRE-Auto-26E9443
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Computational Medicine and Drug Designing Software Market Research Report 2022
BUY CHAPTERS

Global Computational Medicine and Drug Designing Software Market Research Report 2025

Code: QYRE-Auto-26E9443
Report
June 2025
Pages:82
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Entelos Inc
Crown Bioscience
Chemical Computing Group
Nimbus Therapeutics
Schrodinger Llc
Dassault Systemes
Genedata Ag
Biognos Ab
Leadscope Inc
Rhenovia Pharma Limited
Compugen
Certara LP
Simulations Plus
Strand Life Sciences
Prosarix

Computational Medicine and Drug Designing Software Market Size

According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years.

Computational Medicine and Drug Designing Software Market

Computational Medicine and Drug Designing Software Market

The global market for Computational Medicine and Drug Designing Software was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report aims to provide a comprehensive presentation of the global market for Computational Medicine and Drug Designing Software, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Computational Medicine and Drug Designing Software.
The Computational Medicine and Drug Designing Software market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Computational Medicine and Drug Designing Software market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Computational Medicine and Drug Designing Software companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Computational Medicine and Drug Designing Software Market Report

Report Metric Details
Report Name Computational Medicine and Drug Designing Software Market
Accounted market size in year US$ 603 billion
CAGR 5%
Base Year year
Segment by Type
  • Cloud-based
  • On-premise
Segment by Application
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Entelos, Crown Bioscience, Chemical Computing Group, Nimbus Therapeutics, Schrodinger, Dassault Systemes, Genedata, Biognos, Leadscope, Rhenovia Pharma Limited, Compugen, Certara LP, Prosarix, Simulations Plus, Strand Life Sciences
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Computational Medicine and Drug Designing Software company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Computational Medicine and Drug Designing Software Market report?

Ans: The main players in the Computational Medicine and Drug Designing Software Market are Entelos, Crown Bioscience, Chemical Computing Group, Nimbus Therapeutics, Schrodinger, Dassault Systemes, Genedata, Biognos, Leadscope, Rhenovia Pharma Limited, Compugen, Certara LP, Prosarix, Simulations Plus, Strand Life Sciences

What are the Application segmentation covered in the Computational Medicine and Drug Designing Software Market report?

Ans: The Applications covered in the Computational Medicine and Drug Designing Software Market report are Drug Discovery and Development, Computational Physiological Medicine, Disease Modeling, Medical Imaging, Predictive Analysis of Drug Targets

What are the Type segmentation covered in the Computational Medicine and Drug Designing Software Market report?

Ans: The Types covered in the Computational Medicine and Drug Designing Software Market report are Cloud-based, On-premise

Recommended Reports

Medical Imaging Software

Drug Discovery Tools

Healthcare Management

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Computational Medicine and Drug Designing Software Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Cloud-based
1.2.3 On-premise
1.3 Market by Application
1.3.1 Global Computational Medicine and Drug Designing Software Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Drug Discovery and Development
1.3.3 Computational Physiological Medicine
1.3.4 Disease Modeling
1.3.5 Medical Imaging
1.3.6 Predictive Analysis of Drug Targets
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Computational Medicine and Drug Designing Software Market Perspective (2020-2031)
2.2 Global Computational Medicine and Drug Designing Software Growth Trends by Region
2.2.1 Global Computational Medicine and Drug Designing Software Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Computational Medicine and Drug Designing Software Historic Market Size by Region (2020-2025)
2.2.3 Computational Medicine and Drug Designing Software Forecasted Market Size by Region (2026-2031)
2.3 Computational Medicine and Drug Designing Software Market Dynamics
2.3.1 Computational Medicine and Drug Designing Software Industry Trends
2.3.2 Computational Medicine and Drug Designing Software Market Drivers
2.3.3 Computational Medicine and Drug Designing Software Market Challenges
2.3.4 Computational Medicine and Drug Designing Software Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Computational Medicine and Drug Designing Software Players by Revenue
3.1.1 Global Top Computational Medicine and Drug Designing Software Players by Revenue (2020-2025)
3.1.2 Global Computational Medicine and Drug Designing Software Revenue Market Share by Players (2020-2025)
3.2 Global Computational Medicine and Drug Designing Software Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Computational Medicine and Drug Designing Software Revenue
3.4 Global Computational Medicine and Drug Designing Software Market Concentration Ratio
3.4.1 Global Computational Medicine and Drug Designing Software Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Computational Medicine and Drug Designing Software Revenue in 2024
3.5 Global Key Players of Computational Medicine and Drug Designing Software Head office and Area Served
3.6 Global Key Players of Computational Medicine and Drug Designing Software, Product and Application
3.7 Global Key Players of Computational Medicine and Drug Designing Software, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Computational Medicine and Drug Designing Software Breakdown Data by Type
4.1 Global Computational Medicine and Drug Designing Software Historic Market Size by Type (2020-2025)
4.2 Global Computational Medicine and Drug Designing Software Forecasted Market Size by Type (2026-2031)
5 Computational Medicine and Drug Designing Software Breakdown Data by Application
5.1 Global Computational Medicine and Drug Designing Software Historic Market Size by Application (2020-2025)
5.2 Global Computational Medicine and Drug Designing Software Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Computational Medicine and Drug Designing Software Market Size (2020-2031)
6.2 North America Computational Medicine and Drug Designing Software Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Computational Medicine and Drug Designing Software Market Size by Country (2020-2025)
6.4 North America Computational Medicine and Drug Designing Software Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Computational Medicine and Drug Designing Software Market Size (2020-2031)
7.2 Europe Computational Medicine and Drug Designing Software Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Computational Medicine and Drug Designing Software Market Size by Country (2020-2025)
7.4 Europe Computational Medicine and Drug Designing Software Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Computational Medicine and Drug Designing Software Market Size (2020-2031)
8.2 Asia-Pacific Computational Medicine and Drug Designing Software Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Computational Medicine and Drug Designing Software Market Size by Region (2020-2025)
8.4 Asia-Pacific Computational Medicine and Drug Designing Software Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Computational Medicine and Drug Designing Software Market Size (2020-2031)
9.2 Latin America Computational Medicine and Drug Designing Software Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Computational Medicine and Drug Designing Software Market Size by Country (2020-2025)
9.4 Latin America Computational Medicine and Drug Designing Software Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Computational Medicine and Drug Designing Software Market Size (2020-2031)
10.2 Middle East & Africa Computational Medicine and Drug Designing Software Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Computational Medicine and Drug Designing Software Market Size by Country (2020-2025)
10.4 Middle East & Africa Computational Medicine and Drug Designing Software Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Entelos
11.1.1 Entelos Company Details
11.1.2 Entelos Business Overview
11.1.3 Entelos Computational Medicine and Drug Designing Software Introduction
11.1.4 Entelos Revenue in Computational Medicine and Drug Designing Software Business (2020-2025)
11.1.5 Entelos Recent Development
11.2 Crown Bioscience
11.2.1 Crown Bioscience Company Details
11.2.2 Crown Bioscience Business Overview
11.2.3 Crown Bioscience Computational Medicine and Drug Designing Software Introduction
11.2.4 Crown Bioscience Revenue in Computational Medicine and Drug Designing Software Business (2020-2025)
11.2.5 Crown Bioscience Recent Development
11.3 Chemical Computing Group
11.3.1 Chemical Computing Group Company Details
11.3.2 Chemical Computing Group Business Overview
11.3.3 Chemical Computing Group Computational Medicine and Drug Designing Software Introduction
11.3.4 Chemical Computing Group Revenue in Computational Medicine and Drug Designing Software Business (2020-2025)
11.3.5 Chemical Computing Group Recent Development
11.4 Nimbus Therapeutics
11.4.1 Nimbus Therapeutics Company Details
11.4.2 Nimbus Therapeutics Business Overview
11.4.3 Nimbus Therapeutics Computational Medicine and Drug Designing Software Introduction
11.4.4 Nimbus Therapeutics Revenue in Computational Medicine and Drug Designing Software Business (2020-2025)
11.4.5 Nimbus Therapeutics Recent Development
11.5 Schrodinger
11.5.1 Schrodinger Company Details
11.5.2 Schrodinger Business Overview
11.5.3 Schrodinger Computational Medicine and Drug Designing Software Introduction
11.5.4 Schrodinger Revenue in Computational Medicine and Drug Designing Software Business (2020-2025)
11.5.5 Schrodinger Recent Development
11.6 Dassault Systemes
11.6.1 Dassault Systemes Company Details
11.6.2 Dassault Systemes Business Overview
11.6.3 Dassault Systemes Computational Medicine and Drug Designing Software Introduction
11.6.4 Dassault Systemes Revenue in Computational Medicine and Drug Designing Software Business (2020-2025)
11.6.5 Dassault Systemes Recent Development
11.7 Genedata
11.7.1 Genedata Company Details
11.7.2 Genedata Business Overview
11.7.3 Genedata Computational Medicine and Drug Designing Software Introduction
11.7.4 Genedata Revenue in Computational Medicine and Drug Designing Software Business (2020-2025)
11.7.5 Genedata Recent Development
11.8 Biognos
11.8.1 Biognos Company Details
11.8.2 Biognos Business Overview
11.8.3 Biognos Computational Medicine and Drug Designing Software Introduction
11.8.4 Biognos Revenue in Computational Medicine and Drug Designing Software Business (2020-2025)
11.8.5 Biognos Recent Development
11.9 Leadscope
11.9.1 Leadscope Company Details
11.9.2 Leadscope Business Overview
11.9.3 Leadscope Computational Medicine and Drug Designing Software Introduction
11.9.4 Leadscope Revenue in Computational Medicine and Drug Designing Software Business (2020-2025)
11.9.5 Leadscope Recent Development
11.10 Rhenovia Pharma Limited
11.10.1 Rhenovia Pharma Limited Company Details
11.10.2 Rhenovia Pharma Limited Business Overview
11.10.3 Rhenovia Pharma Limited Computational Medicine and Drug Designing Software Introduction
11.10.4 Rhenovia Pharma Limited Revenue in Computational Medicine and Drug Designing Software Business (2020-2025)
11.10.5 Rhenovia Pharma Limited Recent Development
11.11 Compugen
11.11.1 Compugen Company Details
11.11.2 Compugen Business Overview
11.11.3 Compugen Computational Medicine and Drug Designing Software Introduction
11.11.4 Compugen Revenue in Computational Medicine and Drug Designing Software Business (2020-2025)
11.11.5 Compugen Recent Development
11.12 Certara LP
11.12.1 Certara LP Company Details
11.12.2 Certara LP Business Overview
11.12.3 Certara LP Computational Medicine and Drug Designing Software Introduction
11.12.4 Certara LP Revenue in Computational Medicine and Drug Designing Software Business (2020-2025)
11.12.5 Certara LP Recent Development
11.13 Prosarix
11.13.1 Prosarix Company Details
11.13.2 Prosarix Business Overview
11.13.3 Prosarix Computational Medicine and Drug Designing Software Introduction
11.13.4 Prosarix Revenue in Computational Medicine and Drug Designing Software Business (2020-2025)
11.13.5 Prosarix Recent Development
11.14 Simulations Plus
11.14.1 Simulations Plus Company Details
11.14.2 Simulations Plus Business Overview
11.14.3 Simulations Plus Computational Medicine and Drug Designing Software Introduction
11.14.4 Simulations Plus Revenue in Computational Medicine and Drug Designing Software Business (2020-2025)
11.14.5 Simulations Plus Recent Development
11.15 Strand Life Sciences
11.15.1 Strand Life Sciences Company Details
11.15.2 Strand Life Sciences Business Overview
11.15.3 Strand Life Sciences Computational Medicine and Drug Designing Software Introduction
11.15.4 Strand Life Sciences Revenue in Computational Medicine and Drug Designing Software Business (2020-2025)
11.15.5 Strand Life Sciences Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Entelos Inc
Crown Bioscience
Chemical Computing Group
Nimbus Therapeutics
Schrodinger Llc
Dassault Systemes
Genedata Ag
Biognos Ab
Leadscope Inc
Rhenovia Pharma Limited
Compugen
Certara LP
Simulations Plus
Strand Life Sciences
Prosarix
List of Tables
 Table 1. Global Computational Medicine and Drug Designing Software Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Cloud-based
 Table 3. Key Players of On-premise
 Table 4. Global Computational Medicine and Drug Designing Software Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 5. Global Computational Medicine and Drug Designing Software Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global Computational Medicine and Drug Designing Software Market Size by Region (2020-2025) & (US$ Million)
 Table 7. Global Computational Medicine and Drug Designing Software Market Share by Region (2020-2025)
 Table 8. Global Computational Medicine and Drug Designing Software Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 9. Global Computational Medicine and Drug Designing Software Market Share by Region (2026-2031)
 Table 10. Computational Medicine and Drug Designing Software Market Trends
 Table 11. Computational Medicine and Drug Designing Software Market Drivers
 Table 12. Computational Medicine and Drug Designing Software Market Challenges
 Table 13. Computational Medicine and Drug Designing Software Market Restraints
 Table 14. Global Computational Medicine and Drug Designing Software Revenue by Players (2020-2025) & (US$ Million)
 Table 15. Global Computational Medicine and Drug Designing Software Market Share by Players (2020-2025)
 Table 16. Global Top Computational Medicine and Drug Designing Software Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Computational Medicine and Drug Designing Software as of 2024)
 Table 17. Ranking of Global Top Computational Medicine and Drug Designing Software Companies by Revenue (US$ Million) in 2024
 Table 18. Global 5 Largest Players Market Share by Computational Medicine and Drug Designing Software Revenue (CR5 and HHI) & (2020-2025)
 Table 19. Global Key Players of Computational Medicine and Drug Designing Software, Headquarters and Area Served
 Table 20. Global Key Players of Computational Medicine and Drug Designing Software, Product and Application
 Table 21. Global Key Players of Computational Medicine and Drug Designing Software, Date of Enter into This Industry
 Table 22. Mergers & Acquisitions, Expansion Plans
 Table 23. Global Computational Medicine and Drug Designing Software Market Size by Type (2020-2025) & (US$ Million)
 Table 24. Global Computational Medicine and Drug Designing Software Revenue Market Share by Type (2020-2025)
 Table 25. Global Computational Medicine and Drug Designing Software Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 26. Global Computational Medicine and Drug Designing Software Revenue Market Share by Type (2026-2031)
 Table 27. Global Computational Medicine and Drug Designing Software Market Size by Application (2020-2025) & (US$ Million)
 Table 28. Global Computational Medicine and Drug Designing Software Revenue Market Share by Application (2020-2025)
 Table 29. Global Computational Medicine and Drug Designing Software Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 30. Global Computational Medicine and Drug Designing Software Revenue Market Share by Application (2026-2031)
 Table 31. North America Computational Medicine and Drug Designing Software Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 32. North America Computational Medicine and Drug Designing Software Market Size by Country (2020-2025) & (US$ Million)
 Table 33. North America Computational Medicine and Drug Designing Software Market Size by Country (2026-2031) & (US$ Million)
 Table 34. Europe Computational Medicine and Drug Designing Software Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 35. Europe Computational Medicine and Drug Designing Software Market Size by Country (2020-2025) & (US$ Million)
 Table 36. Europe Computational Medicine and Drug Designing Software Market Size by Country (2026-2031) & (US$ Million)
 Table 37. Asia-Pacific Computational Medicine and Drug Designing Software Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 38. Asia-Pacific Computational Medicine and Drug Designing Software Market Size by Region (2020-2025) & (US$ Million)
 Table 39. Asia-Pacific Computational Medicine and Drug Designing Software Market Size by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Computational Medicine and Drug Designing Software Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 41. Latin America Computational Medicine and Drug Designing Software Market Size by Country (2020-2025) & (US$ Million)
 Table 42. Latin America Computational Medicine and Drug Designing Software Market Size by Country (2026-2031) & (US$ Million)
 Table 43. Middle East & Africa Computational Medicine and Drug Designing Software Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 44. Middle East & Africa Computational Medicine and Drug Designing Software Market Size by Country (2020-2025) & (US$ Million)
 Table 45. Middle East & Africa Computational Medicine and Drug Designing Software Market Size by Country (2026-2031) & (US$ Million)
 Table 46. Entelos Company Details
 Table 47. Entelos Business Overview
 Table 48. Entelos Computational Medicine and Drug Designing Software Product
 Table 49. Entelos Revenue in Computational Medicine and Drug Designing Software Business (2020-2025) & (US$ Million)
 Table 50. Entelos Recent Development
 Table 51. Crown Bioscience Company Details
 Table 52. Crown Bioscience Business Overview
 Table 53. Crown Bioscience Computational Medicine and Drug Designing Software Product
 Table 54. Crown Bioscience Revenue in Computational Medicine and Drug Designing Software Business (2020-2025) & (US$ Million)
 Table 55. Crown Bioscience Recent Development
 Table 56. Chemical Computing Group Company Details
 Table 57. Chemical Computing Group Business Overview
 Table 58. Chemical Computing Group Computational Medicine and Drug Designing Software Product
 Table 59. Chemical Computing Group Revenue in Computational Medicine and Drug Designing Software Business (2020-2025) & (US$ Million)
 Table 60. Chemical Computing Group Recent Development
 Table 61. Nimbus Therapeutics Company Details
 Table 62. Nimbus Therapeutics Business Overview
 Table 63. Nimbus Therapeutics Computational Medicine and Drug Designing Software Product
 Table 64. Nimbus Therapeutics Revenue in Computational Medicine and Drug Designing Software Business (2020-2025) & (US$ Million)
 Table 65. Nimbus Therapeutics Recent Development
 Table 66. Schrodinger Company Details
 Table 67. Schrodinger Business Overview
 Table 68. Schrodinger Computational Medicine and Drug Designing Software Product
 Table 69. Schrodinger Revenue in Computational Medicine and Drug Designing Software Business (2020-2025) & (US$ Million)
 Table 70. Schrodinger Recent Development
 Table 71. Dassault Systemes Company Details
 Table 72. Dassault Systemes Business Overview
 Table 73. Dassault Systemes Computational Medicine and Drug Designing Software Product
 Table 74. Dassault Systemes Revenue in Computational Medicine and Drug Designing Software Business (2020-2025) & (US$ Million)
 Table 75. Dassault Systemes Recent Development
 Table 76. Genedata Company Details
 Table 77. Genedata Business Overview
 Table 78. Genedata Computational Medicine and Drug Designing Software Product
 Table 79. Genedata Revenue in Computational Medicine and Drug Designing Software Business (2020-2025) & (US$ Million)
 Table 80. Genedata Recent Development
 Table 81. Biognos Company Details
 Table 82. Biognos Business Overview
 Table 83. Biognos Computational Medicine and Drug Designing Software Product
 Table 84. Biognos Revenue in Computational Medicine and Drug Designing Software Business (2020-2025) & (US$ Million)
 Table 85. Biognos Recent Development
 Table 86. Leadscope Company Details
 Table 87. Leadscope Business Overview
 Table 88. Leadscope Computational Medicine and Drug Designing Software Product
 Table 89. Leadscope Revenue in Computational Medicine and Drug Designing Software Business (2020-2025) & (US$ Million)
 Table 90. Leadscope Recent Development
 Table 91. Rhenovia Pharma Limited Company Details
 Table 92. Rhenovia Pharma Limited Business Overview
 Table 93. Rhenovia Pharma Limited Computational Medicine and Drug Designing Software Product
 Table 94. Rhenovia Pharma Limited Revenue in Computational Medicine and Drug Designing Software Business (2020-2025) & (US$ Million)
 Table 95. Rhenovia Pharma Limited Recent Development
 Table 96. Compugen Company Details
 Table 97. Compugen Business Overview
 Table 98. Compugen Computational Medicine and Drug Designing Software Product
 Table 99. Compugen Revenue in Computational Medicine and Drug Designing Software Business (2020-2025) & (US$ Million)
 Table 100. Compugen Recent Development
 Table 101. Certara LP Company Details
 Table 102. Certara LP Business Overview
 Table 103. Certara LP Computational Medicine and Drug Designing Software Product
 Table 104. Certara LP Revenue in Computational Medicine and Drug Designing Software Business (2020-2025) & (US$ Million)
 Table 105. Certara LP Recent Development
 Table 106. Prosarix Company Details
 Table 107. Prosarix Business Overview
 Table 108. Prosarix Computational Medicine and Drug Designing Software Product
 Table 109. Prosarix Revenue in Computational Medicine and Drug Designing Software Business (2020-2025) & (US$ Million)
 Table 110. Prosarix Recent Development
 Table 111. Simulations Plus Company Details
 Table 112. Simulations Plus Business Overview
 Table 113. Simulations Plus Computational Medicine and Drug Designing Software Product
 Table 114. Simulations Plus Revenue in Computational Medicine and Drug Designing Software Business (2020-2025) & (US$ Million)
 Table 115. Simulations Plus Recent Development
 Table 116. Strand Life Sciences Company Details
 Table 117. Strand Life Sciences Business Overview
 Table 118. Strand Life Sciences Computational Medicine and Drug Designing Software Product
 Table 119. Strand Life Sciences Revenue in Computational Medicine and Drug Designing Software Business (2020-2025) & (US$ Million)
 Table 120. Strand Life Sciences Recent Development
 Table 121. Research Programs/Design for This Report
 Table 122. Key Data Information from Secondary Sources
 Table 123. Key Data Information from Primary Sources
 Table 124. Authors List of This Report


List of Figures
 Figure 1. Computational Medicine and Drug Designing Software Picture
 Figure 2. Global Computational Medicine and Drug Designing Software Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Computational Medicine and Drug Designing Software Market Share by Type: 2024 VS 2031
 Figure 4. Cloud-based Features
 Figure 5. On-premise Features
 Figure 6. Global Computational Medicine and Drug Designing Software Market Size by Application (2020-2031) & (US$ Million)
 Figure 7. Global Computational Medicine and Drug Designing Software Market Share by Application: 2024 VS 2031
 Figure 8. Drug Discovery and Development Case Studies
 Figure 9. Computational Physiological Medicine Case Studies
 Figure 10. Disease Modeling Case Studies
 Figure 11. Medical Imaging Case Studies
 Figure 12. Predictive Analysis of Drug Targets Case Studies
 Figure 13. Computational Medicine and Drug Designing Software Report Years Considered
 Figure 14. Global Computational Medicine and Drug Designing Software Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 15. Global Computational Medicine and Drug Designing Software Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 16. Global Computational Medicine and Drug Designing Software Market Share by Region: 2024 VS 2031
 Figure 17. Global Computational Medicine and Drug Designing Software Market Share by Players in 2024
 Figure 18. Global Top Computational Medicine and Drug Designing Software Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Computational Medicine and Drug Designing Software as of 2024)
 Figure 19. The Top 10 and 5 Players Market Share by Computational Medicine and Drug Designing Software Revenue in 2024
 Figure 20. North America Computational Medicine and Drug Designing Software Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 21. North America Computational Medicine and Drug Designing Software Market Share by Country (2020-2031)
 Figure 22. United States Computational Medicine and Drug Designing Software Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Canada Computational Medicine and Drug Designing Software Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Europe Computational Medicine and Drug Designing Software Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. Europe Computational Medicine and Drug Designing Software Market Share by Country (2020-2031)
 Figure 26. Germany Computational Medicine and Drug Designing Software Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. France Computational Medicine and Drug Designing Software Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. U.K. Computational Medicine and Drug Designing Software Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Italy Computational Medicine and Drug Designing Software Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Russia Computational Medicine and Drug Designing Software Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Nordic Countries Computational Medicine and Drug Designing Software Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Asia-Pacific Computational Medicine and Drug Designing Software Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Asia-Pacific Computational Medicine and Drug Designing Software Market Share by Region (2020-2031)
 Figure 34. China Computational Medicine and Drug Designing Software Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Japan Computational Medicine and Drug Designing Software Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. South Korea Computational Medicine and Drug Designing Software Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Southeast Asia Computational Medicine and Drug Designing Software Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. India Computational Medicine and Drug Designing Software Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Australia Computational Medicine and Drug Designing Software Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Latin America Computational Medicine and Drug Designing Software Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Latin America Computational Medicine and Drug Designing Software Market Share by Country (2020-2031)
 Figure 42. Mexico Computational Medicine and Drug Designing Software Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Brazil Computational Medicine and Drug Designing Software Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Middle East & Africa Computational Medicine and Drug Designing Software Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Middle East & Africa Computational Medicine and Drug Designing Software Market Share by Country (2020-2031)
 Figure 46. Turkey Computational Medicine and Drug Designing Software Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. Saudi Arabia Computational Medicine and Drug Designing Software Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. UAE Computational Medicine and Drug Designing Software Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 49. Entelos Revenue Growth Rate in Computational Medicine and Drug Designing Software Business (2020-2025)
 Figure 50. Crown Bioscience Revenue Growth Rate in Computational Medicine and Drug Designing Software Business (2020-2025)
 Figure 51. Chemical Computing Group Revenue Growth Rate in Computational Medicine and Drug Designing Software Business (2020-2025)
 Figure 52. Nimbus Therapeutics Revenue Growth Rate in Computational Medicine and Drug Designing Software Business (2020-2025)
 Figure 53. Schrodinger Revenue Growth Rate in Computational Medicine and Drug Designing Software Business (2020-2025)
 Figure 54. Dassault Systemes Revenue Growth Rate in Computational Medicine and Drug Designing Software Business (2020-2025)
 Figure 55. Genedata Revenue Growth Rate in Computational Medicine and Drug Designing Software Business (2020-2025)
 Figure 56. Biognos Revenue Growth Rate in Computational Medicine and Drug Designing Software Business (2020-2025)
 Figure 57. Leadscope Revenue Growth Rate in Computational Medicine and Drug Designing Software Business (2020-2025)
 Figure 58. Rhenovia Pharma Limited Revenue Growth Rate in Computational Medicine and Drug Designing Software Business (2020-2025)
 Figure 59. Compugen Revenue Growth Rate in Computational Medicine and Drug Designing Software Business (2020-2025)
 Figure 60. Certara LP Revenue Growth Rate in Computational Medicine and Drug Designing Software Business (2020-2025)
 Figure 61. Prosarix Revenue Growth Rate in Computational Medicine and Drug Designing Software Business (2020-2025)
 Figure 62. Simulations Plus Revenue Growth Rate in Computational Medicine and Drug Designing Software Business (2020-2025)
 Figure 63. Strand Life Sciences Revenue Growth Rate in Computational Medicine and Drug Designing Software Business (2020-2025)
 Figure 64. Bottom-up and Top-down Approaches for This Report
 Figure 65. Data Triangulation
 Figure 66. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Nano Dimension

SIMILAR REPORTS

Medical 3D Software Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Medical Device Sales Software Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Hospital Software Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Medical Simulation Software Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Medical Image Software Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Hospital Billing Software Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Pregnancy Risk Calculation Software Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Physician Scheduling Software Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Nuclear Medicine Software Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Healthcare Software Development Service Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Medical Credentialing Software Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Hospital Management Software Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Nuclear Medicine Software System Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Healthcare Revenue Cycle Management Software Market
Digital Visitor Management Software for Healthcare Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Artificial Intelligence Medical Software Market Research Report 2025
Diabetes Management Software Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Medical Image Exchange Software Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Healthcare Simulation Software Market Research Report 2024
Cardiovascular Digital Solution Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

RELATED REPORTS

Global Cephalosporin APIs and Cephalosporin Intermediates Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-19G16926
Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global ELISA Immunoassay Plates Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-7Z17064
Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global Ready-to-Use ELISA Kits Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-20P20045
Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global Moxidectin Injection Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-3Z19977
Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions